Aurobindo Pharma Limited (NSE:AUROPHARMA)
1,077.80
-12.30 (-1.13%)
Oct 8, 2025, 2:30 PM IST
Aurobindo Pharma Revenue
Aurobindo Pharma had revenue of 78.68B INR in the quarter ending June 30, 2025, with 3.98% growth. This brings the company's revenue in the last twelve months to 320.25B, up 7.76% year-over-year. In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B with 9.39% growth.
Revenue (ttm)
320.25B
Revenue Growth
+7.76%
P/S Ratio
1.98
Revenue / Employee
11.56M
Employees
27,707
Market Cap
633.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 317.24B | 27.22B | 9.39% |
Mar 31, 2024 | 290.02B | 41.46B | 16.68% |
Mar 31, 2023 | 248.55B | 14.00B | 5.97% |
Mar 31, 2022 | 234.55B | -13.19B | -5.32% |
Mar 31, 2021 | 247.75B | 16.76B | 7.26% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Aurobindo Pharma News
- 12 days ago - Why are Aurobindo Pharma shares falling over 2% today? Explained - Business Upturn
- 12 days ago - Gland Pharma down 4%, Sun Pharma slips 2.6%, Dr Reddy’s down 2%, Zydus nearly 3%, Aurobindo down 2% as Trump’s 100% pharma tariff jolts sector - Business Upturn
- 12 days ago - Indian pharma stocks in focus as Trump announces 100% tariff on branded drugs - Business Upturn
- 19 days ago - Aurobindo Pharma reports fire incident at its Andhra Pradesh unit - Business Upturn
- 19 days ago - Aurobindo Pharma’s CuraTeQ Biologics successfully completes Phase 3 study for denosumab biosimilar - Business Upturn
- 20 days ago - Top stocks to watch today, September 18: TVS Motor, Biocon, Aurobindo Pharma, Bandhan Bank, Federal Bank and more - Business Upturn
- 27 days ago - Why are Aurobindo Pharma shares up 5% today? Know More - Business Upturn
- 4 weeks ago - Top stocks to watch today, September 8: BHEL, NTPC Green, Adani Green, Aurobindo Pharma and more - Business Upturn